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Abstract. As nitric oxide (NO) expression levels are lower in 
hepatocytes compared with other cell types, it is difficult to 
quantify this compound via Griess assay. The aim of the present 
study was to quantify NO concentration in the cell culture 
medium from a subgenomic hepatitis C virus (HCV)‑replicon 
expressing Huh‑7 cell system using a high‑performance 
liquid chromatography (HPLC)‑fluorescence detector in the 
presence or absence of acetylsalicylic acid (ASA) treatment. 
HCV‑replicon cells were incubated with ASA (4 mM) for 
24, 48 and 72 h. Thereafter, the medium was collected to 
measure nitrites (NO2
-) as an indirect indicator of NO levels 
using diaminonaphtalene as a derivate agent. NO levels were 
significantly higher (1.7‑fold) in Huh‑7 replicon cells treated 
with ASA (72 h post‑treatment) than untreated cells (P<0.05); 
NO inhibitor reduced ~30% the level of NO in Huh‑7 replicon 
cells treated with ASA (48 h post‑treatment; P<0.05). The find-
ings suggested that the HPLC‑fluorescence method provided 
an accurate and efficient measurement of NO production in 
Huh‑7‑HCV‑replicon cells culture medium.
Introduction
Nitric oxide (NO) is an endogenous free radical that has previ-
ously been challenging to measure within blood samples, due 
to its reactive nature and short half‑life; however, the Griess 
assay is currently widely applied to measure NO via the 
quantification of nitrite (NO2
-); Wen and Paik (1) indirectly 
measured aliphatic β‑nitroalcohols and the Greiss assay has 
also been used to investigate the NO‑dependent egrada-
tion pathway of CYP2C22 (2). Jansen et al (3) also used the 
Greiss assay to study the nitric oxide synthase (NOS) active 
site. As NO reacts with molecular oxygen to generate nitrate 
(NO3-) and NO2-, the latter is soluble in water and is easier to 
detect (4). The NO2- is acidified (usually with phosphoric acid) 
to form nitrous acid to allow diazotization via the nitrosation 
of sulfanilic acid. Once sulfanilamide is produced, the reaction 
with N‑1‑napthylethylenediamine dihydrochloride produces a 
purple chromophore with an absorbance at 540 nm (5).
The Griess reaction is inexpensive, simple and fast; however, 
the limit of detection is ~0.5 µM, which restricts the applica-
tion of this colorimetric method for quantifying micromolar, 
nanomolar and picomolar levels of NO2-, and therefore physi-
ological amounts (6). Furthermore, the media composition in 
biological systems may alter the measurements of NO due to 
the presence of other proteins, such as hemoglobin, which is 
also detected at 540 nm (7). More sophisticated methods have 
also been used to measure biological NOS. Independently of 
whether it is a prokaryotic or eukaryotic culture, NO may be 
classified via direct or indirect methods. In the latter methods, 
other biological components may be measured in addition to 
NO2- or NO3-, such as guanosine monophosphase (cGMP) (8), 
L‑citrulline (9) and nitrosothiols (10).
As NO is a free radical, electron paramagnetic resonance 
spectroscopy may be used as a direct method to estimate NO 
levels; however low levels of NO, poor sensitivity and the 
complexity of the evaluation of the results, reduces the efficacy 
of this method in biological contexts (11,12).
Fluorescence assays are more precise, indirect methods to 
measure NO with a sensitivity of 0.6‑0.8 nM. This technique 
involves a reaction between a secondary metabolite of NO and a 
derivatizing agent, which generates a fluorescent molecule (6). 
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This technique has been used in biological samples, including 
culture with mammalian cells as it allows real‑time measure-
ments, ease of use and high sensitivity (13,14).
High‑performance liquid chromatography (HPLC) has 
been used previously to quantify NO (15) due to its high 
sensitivity (16) and was identified as a potentially more useful 
method to quantify NO in hepatocyte cell culture, based on the 
reaction of NO2 with 2, 3‑diaminonaphthalene (DAN) as an 
indicator of NO formation, under acidic conditions to obtain 
the fluorescent product 2, 3‑naphthotriazole (NAT) (13). DAN 
has excitation and emission wavelengths of 375 and 415 nm, 
respectively, and a 10‑30 nM detection limit (14).
NO has numerous molecular targets in various biological 
schemes, for instance in the cardiovascular system, it stimu-
lates cardioprotective signaling pathways (11); whereas in the 
nervous system it modulates synaptic functions (17), and has 
implications in learning, memory and visual recognition (18). 
Through endogenous metabolic pathways, NO is mainly 
synthesized by three different isoforms of NOS depending on 
the cell type and stimulus: Neuronal NOS (nNOS or NOS I), 
endothelial NOS (eNOS or NOS III) and inducible NOS (iNOS 
or NOS II) (19).
It has previously been demonstrated that acetylsalicylic 
acid (ASA) exhibits antiviral properties against hepatitis C 
virus (HCV) (20). Therefore, one possible explication for the 
antiviral properties of ASA is that it may be mediated by the 
antioxidant properties of SOD (21). In addition, it has been 
confirmed in our laboratory that hepatocytes increase NO 
expression when exposed to higher concentrations of ASA. 
However, as NO is produced in the picomolar range within 
hepatocyte cells culture (5), more precise quantification tech-
niques are required.
The aim of the present study was to measure NO in culture 
medium of subgenomic HCV‑replicon expressing Huh‑7 cells 
following treatment with ASA.
Materials and methods
Cell culture and ASA treatment. Human liver Huh‑7 cells 
containing HCV subgenomic replicon from genotype 1b 
(harboring the subgenomic HCV replicon I389/NS3‑30), the 
original wild‑type pFKI389‑NS3‑3' replicon HCV from geno-
type 1b and the generation of Huh7 HCV replicon hepatoma 
cells expressing HCV non‑structural proteins have been previ-
ously described (22) and were kindly donated by Dr Volker 
Lohmann (University Hospital Heidelberg, Heidelberg, 
Germany) (23) were cultured in Advanced Dulbecco's modi-
fied Eagle's medium (Gibco; Thermo Fisher Scientific, Inc., 
Waltham, MA, USA) supplemented with 2% heat‑inactivated 
fetal bovine serum, 1% non‑essential amino acids, 100 U 
penicillin G, and 100 µg streptomycin/ml (all Gibco; Thermo 
Fisher Scientific, Inc.) at 37˚C in a humidified atmosphere 
with 5% CO2. Cells were maintained in culture in the presence 
of 500 µg/ml G418 (Gibco; Thermo Fisher Scientific, Inc.) 
selection agent. Huh‑7‑HCV‑replicon cells were plated the 
previous day, media was replaced and cells were treated with 
4 mM ASA at 37˚C for 24, 48 and 72 h (Sigma‑Aldrich; Merck 
KGaA, Darmstadt, Germany). Alamar Blue (Invitrogen; 
Thermo Fisher Scientific, Inc.) was used to determine whether 
there were any cytotoxic effects; none were observed.
Cell viability assay. Cell viability was assessed in Huh‑7 cells 
using alamar blue in 96‑well plates at 37˚C for 24, 48 and 72 h 
post‑incubation. The absorbance was monitored at 570 and 
600 nm.
HPLC system. A Waters HPLC system (Waters Corporation, 
Milford, MA, USA) including a 600E quaternary pump 
equipped with a column oven, a 717p automatic injector and 
a 2475 multi‑wavelength fluoresce detector was used. The 
system was controlled by the Empower software version. 2.0 
(Waters, Elstree, UK) and the information was processed 
with the same software. A standard curve was generated with 
NO2- stock. The NO production was quantified in the culture 
medium through the measurement of nitrites NO2
- using 
the HPLC system with a fluorescence detector; λ excitation 
375 nm and λ emission 415 nm.
Sample preparation and NO quantif ication by HPLC 
analysis. Briefly, 100 µl supplemented culture medium 
(blank) or 100 µl medium derived from a viral cell culture 
(45,000 cells) was mixed with 200 µl analytical grade 
acetonitrile. Samples were homogenized using a vortex 
for 30 sec and centrifuged at 7,800 x g for 30 min at room 
temperature. The supernatant was recovered and the solvent 
was evaporated using a Savant VLP80 Vacuum Pump‑Dry 
Compressor for 3‑4 h. Each sample was dehydrated as in the 
previous step and then reconstituted in 100 µl Milli‑Q H2O. 
A total of 1 mg 2'‑DAN (Sigma‑Aldrich; Merck KGaA) was 
mixed with 1 ml 0.62 M HCl. For each sample (100 µl), 10 µl 
DAN was added for the conversion to fluorescent NAT. Tubes 
were incubated at 27˚C for 10 min. Subsequently, 5 µl 2.8 M 
NaOH was added. These mixtures were directly used for the 
chromatographic analysis. The mixture was injected into 
the HPLC equipment using a flow of 1 ml/min and a mobile 
phase of phosphate:methanol buffer (50:50) under isocratic 
conditions; 375 and 415 nm were selected as excitation 
and emission wavelengths, respectively. Each sample was 
analysed by triplicate.
Mobile phase with 50% of 15 mM sodium phosphate buffer 
(pH=7.5) and 50% methanol, was pumped through the HPLC 
system at a flow rate of 1 ml/min. A Symmetry 4.6x150 mm, 
reversed‑phase C18 column and a guard‑column packed with 
C18 were used for the assay, and the inner column was heated 
to 37˚C. A total of 10 µl of the derivative nitrite solution was 
injected into the HPLC system. Fluorescence was monitored 
with an excitation wavelength of 375 nm, emission of 415 nm 
and a gain of 10.
Measurement of NO. The calibration curve was produced 
using the culture medium as matrix and the interference by 
ASA was eliminated by measuring 4 mM ASA without NO2
- 
standard (125, 250, 500, 750 and 1,000 pM), and was validated 
by linear regression. The medium cell‑derived Huh‑7‑HCV 
replicon‑exposed to 4 mM ASA was processed with aceto-
nitrile to remove proteins and retain only the salt deposits. 
Each sample was incubated at 27˚C for 10 min with 1 mg 
DAN‑derivative agent to yield a fluorescent signal, detected by 
HPLC with a fluorescence detector; λ excitation 375 nm and 
λ emission 415 nm. The resulting readings were interpolated 
in the calibration curve.
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As controls of NO production, arginine (inducer of NO) 
and inhibitor of NO (L‑NIL) were selected to confirm whether 
the cell model was responsive to ASA stimuli and therefore 
regulate NO production.
Statistical analysis. Experiments were performed in tripli-
cate and were analyzed using one‑way analysis of variance 
and Dunnett's test. The calibration curves were evaluated 
by linearity (y= mx+b) and the coefficient of variation was 
calculated using the following formula: % coefficient of varia-
tion (CV)=[(standard deviation/mean) x100] to evaluate the 
precision between the triplicates. Data are presented as the 
mean ± standard deviation. P<0.05 was considered to indicate 
a statistically significant difference. The data was analyzed 
using SPSS version 20 (IBM Corp., Armonk, NY, USA).
Results
Calibration curve linearity and precision. The calibra-
tion curve was prepared using different concentrations 
of NO2- standard (125, 250, 500, 750 and 1,000 pM); these 
concentrations were assayed in triplicate. The curve presented 
good linearity (R2=0.9206) and the equation obtained was 
y=0.9418x+2.4122 (x=NO pM; y=fluorescense unit). The CV 
range was 2.0‑9.1%. In the chromatograms, single peaks were 
observed with ~3.2 min as retention time (Fig. 1).
Determination of NO in Huh‑7‑HCV‑replicon cells culture 
medium. Each sample was incubated with DAN (derivative 
agent) and thereafter analyzed by HPLC. NO levels were 
significantly higher (1.7 fold) in Huh‑7 replicon cells treated 
with ASA at 72 h post‑treatment compared with NO levels 
from untreated cells (Fig. 2).
To identify non-cytotoxic concentrations of the control 
solutions in Huh‑7 cell line, a cell viability assay with alamar 
blue was performed (Fig. 3A and B); 1,000 µM was selected 
for arginine and 250 µM was selected for L‑NIL as the 
non‑cytotoxic concentrations in the model (Table I).
At 72 h arginine treatment, NO levels increased (2.3 fold; 
Fig. 4A), whereas NO levels decreased ~30% at 48 h (P<0.05; 
Fig. 4B) in Huh‑7 replicon cells treated with L‑NIL compared 
with in untreated cells.
Discusion
Hepatocytes produce NO in picomolar levels (6), therefore it 
is difficult to detect and quantify NO levels within them. In 
the present study, the HPLC‑fluorescence detector method 
was employed. The aim of the present study was to describe 
a simple and precise methodology to quantify low concentra-
tions of NO2-.
Figure 1. (A) Resulting signal‑high‑performance liquid chromatography for samples with a retention time of ~3.2 min for NO2
-. (B) Standard curve of NO2
-. 
(C) % CV for calibration curve.
Figure 2. Effect of ASA treatment on NO synthesis in Huh‑7‑replicon 
cells. NO production was 1.7‑fold higher in Huh‑7‑replicon cells at 72 h 
post‑treatment, vs. the negative control. *P<0.05 vs. negative control. ASA, 
acetylsalicylic acid, NO, nitric oxide; CV, coefficient of variation.
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In a previous study performed in our laboratory, 
ASA increased the activity and expression of superoxide 
dismutase enzyme (20), which suggested that the antiviral 
activity of ASA on HCV (22) is mediated, at least in part, by 
its antioxidant properties. Therefore, the present study aimed 
to quantify variations in NO levels upon this event under 
different conditions.
It has been previously reported that iNOS‑derived NO 
has antiviral properties (4). The transcription factors nuclear 
factor-κB and interferon regulatory factor 1 induce the 
expression of iNOS to stimulate antiviral activity to inhibit 
human herpes simplex virus 1 replication in fibroblasts and 
macrophages (24); however the mechanism by which it exerts 
the antiviral activity requires further investigation (25). In 
addition, ASA has been reported to increase NO production 
in endothelial cells via the NO‑cGMP signaling pathway, 
exhibiting numerous beneficial effects in patients with chronic 
stable coronary disease (26).
To investigate whether ASA was able to increase the 
levels of NO in liver cells, Huh‑7‑HCV replicon cells were 
exposed to 4 mM ASA for 24, 48 and 72 h. A time‑dependent 
increase by 1.7‑fold after 72 h of exposure was observed, 
confirming the potential of ASA to induce the production of 
NO. As a control parameter, the levels of NO were measured 
in cells exposed to 1,000 µM arginine or 250 µM L‑NIL 
(inducer and inhibitor of NO respectively). An increase in 
the levels of NO was observed in cells exposed to arginine, 
equivalent to two orders of magnitude, whereas L‑NIL 
reduced NO production and iNOS expression at the tran-
scriptional level. NO was previously quantified using the 
Griess method (27), but the detection range of the calibra-
tion curve using Griess method was 1.56‑100 µM, whereas 
for the HPLC‑fluorescence method the range was 125‑1,000 
pM. Therefore, HPLC may be more useful for the detection 
of low NO concentrations.
Figure 4. Role of ARG and L‑NIL on NO synthesis in Huh‑7‑replicon cells. 
(A) ARG increased the amount of NO as did ASA, whereas (B) L‑NIL 
inhibited its production. *P<0.05 vs. negative control. ARG, arginine; L‑NIL 
inhibitor of nitric oxide; NO, nitric oxide.
Table I. Cell viability assay, measuring the percentage of 
viable cells using alamar blue for 500 and 1,000 µM ARG, 
and with 100 and 500 µM L‑NIL at 24, 48 and 72 h.
A, ARG
Time (h) 0 µM (%) 500 µM (%) 1,000 µM (%)
24 100.00 79.30±12.8 83.00±2.00
48 100.00 77.60±7.70   87.60±10.00
72 100.00 91.00±8.70 95.00±7.20
B, L‑NIL
Time (h) 0 µM (%) 100 µM (%) 500 µM (%)
24 100.00 90.33±3.21 85.00±5.29
48 100.00 84.00±4.35 82.33±3.05
72 100.00 93.30±7.23 97.00±6.08
Data are presented as the mean ± standard deviation. ARG, arginine; 
L‑NIL, inhibitor of nitric oxide.
Figure 3. Cell viability assay for ARG and L‑NIL. The following 
non‑cytotoxic concentrations were selected: (A) 1,000 µM for ARG and 
(B) 250 µM for L‑NIL. ARG, arginine; L‑NIL, inhibitor of nitric oxide.
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Marzinzig, et al (28) previously compared and improved 
standard methods to determine NO2-, NO3- and S‑nitrosothiol 
levels in cell culture supernatants. The conventional Griess 
reaction was modified by replacing sulfanilamide with 
dapsone (4,4'‑diamino‑diphenylsulfone) and the NO2
- levels 
were measured. The modification, along with ultrafiltration of 
the samples, resulted in an enhanced sensitivity to measure 
NO2- at 0.2 µM. The detection limit was further improved to 
0.02 µM when NO2
- was identified by DAN.
Li et al (29) previously separated NAT on a 5‑micron 
reverse‑phase C18 column (inner diameter, 150x4.6 mm) 
guarded by a 40‑µm reverse‑phase C18 column (inner 
diameter, 50x4.6 mm), and eluted with 15 mM sodium phos-
phate buffer (pH 7.5) containing 50% methanol (flow‑rate, 
1.3 ml/min). Fluorescence was monitored with excitation at 
375 nm and emission at 415 nm with fluorescence intensity 
of NAT was linear with NO2- or NO3- concentrations ranging 
from 12.5‑2,000 nM, whereas the curve in the present study 
was linear between 125 and 1,000 pM.
In the present study, the supernatant media was subjected 
to evaporation with vacuum and cooling to obtain the salt 
deposits containing NO2
-, salts were subsequently reacted with 
DAN agent for derivatization under acidic conditions (HCl), 
which reacts with NO2- to form a fluorescent molecule, NAT. 
The reaction was performed for 10 min at 27˚C and the product 
was stabilized with NaOH. The product of the derivatization 
was injected (10 µl) into a C18 reverse phase column with a 
flow of 1 ml/min using as a mobile phase a mixture of 15 mM 
phosphate buffer pH 7.5 + methanol in a 50:50 ratio under 
isocratic conditions (the same proportion is always maintained 
in the mobile phase mixture). Finally, the signal was detected 
by fluorescence with a 375 nm excitation wavelength and an 
emission of 415 nm.
The modulation of NO in the presence of ASA in hepa-
tocarcinoma cells with the structural proteins of HCV was 
quantified in the present study. Therefore, it may be of impor-
tance to analyze the effects of NO against the treatment with 
the complete viral particles.
NO is a soluble and highly labile gas that is released by 
the conversion of the amino acid L‑arginine to L‑citrulline. 
For the synthesis of NO, in addition to L‑arginine as substrate, 
the presence of calmodulin (CaM) and four other cofactors is 
required: Flavin mononucleotide (FMN), flavin adenine dinu-
cleotide (FAD), tetrahydrobloptenin (TBH) and nicotinamide 
adenine dinucleotide phosphate (NADPH) (30). This reaction 
is catalyzed by the enzyme NOS and can be inhibited by struc-
tural derivatives of the amino acids N‑mono‑methyl‑L‑arginine 
and N‑nitro‑L‑arginine methyl esters (31).
When CaM is not bound to the enzyme, the electrons 
donated by NAPDH do not flow from the reductase domain 
to the oxygenase domain, but are accepted by cytochrome c 
and other electron acceptors (32). In the presence of CaM, 
the electrons donated by NADPH are transported by FAD 
and by FMN to the heme group. L‑arginine is converted to 
N‑hydroxyalanine, then to NO and L‑citrulline (33). A limita-
tion of the present study was the fact that it was an in vitro 
investigation. The results of the present study should be vali-
dated in samples from patients infected with HCV.
In conclusion, the HPLC‑fluorometric method was 
confirmed to have the precision and linearity to produce 
confident measures for NO levels in the cellular medium 
and therefore may be used for routine monitoring of NO 
variation under various cell media conditions. In the present 
study, ASA was observed to induce NO production in 
Huh‑7‑HCV‑replicon cells. These results suggest that NO 
may be associated with the negative regulation of ASA on 
HCV, particularly as NO is associated with antiviral proper-
ties on certain viruses, including Epstein Barr, Dengue and 
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